Anette Varbo

Herlev, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Feasibility of remnant cholesterol as a therapeutic target for atherosclerotic cardio-vascular disease.

Feasibility of remnant cholesterol as a therapeutic target for atherosclerotic cardio-vascular disease.

Journal: Expert opinion on therapeutic targets

Published: February 27, 2026

Lipid-related cardiovascular risk beyond low-density lipoprotein cholesterol.

Lipid-related cardiovascular risk beyond low-density lipoprotein cholesterol.

Journal: Heart (British Cardiac Society)

Published: September 09, 2025

VLDL cholesterol and ASCVD risk: A population-based study.

VLDL cholesterol and ASCVD risk: A population-based study.

Journal: Journal of clinical lipidology

Published: August 12, 2025

Risk reduction of ASCVD attributed to lowering of remnant cholesterol from statins, fibrates, APOC3 inhibitors, and ANGPTL3 inhibitors: a cohort study.

Risk reduction of ASCVD attributed to lowering of remnant cholesterol from statins, fibrates, APOC3 inhibitors, and ANGPTL3 inhibitors: a cohort study.

Journal: Atherosclerosis

Published: April 25, 2025

The association between small dense low-density lipoprotein cholesterol and peripheral artery disease: a large-scale cohort study and meta-analysis.

The association between small dense low-density lipoprotein cholesterol and peripheral artery disease: a large-scale cohort study and meta-analysis.

Journal: European journal of preventive cardiology

Published: December 20, 2024

Remnant Cholesterol: Quantification, Concentrations by Sex and Age, and Risk of Ischemic Heart Disease.

Remnant Cholesterol: Quantification, Concentrations by Sex and Age, and Risk of Ischemic Heart Disease.

Journal: Clinical chemistry

Published: August 07, 2024

Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial.

Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial.

Journal: The lancet. Diabetes & endocrinology

Published: April 05, 2024

Healthcare utilization associated with obesity management in Ontario, Canada.

Healthcare utilization associated with obesity management in Ontario, Canada.

Journal: Clinical obesity

Published: January 17, 2024

Obesity, Cardiorenal Comorbidities, and Risk of Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction.

Obesity, Cardiorenal Comorbidities, and Risk of Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction.

Journal: Mayo Clinic proceedings

Published: May 03, 2023

Hypertriglyceridemia-Associated Pancreatitis: New Concepts and Potential Mechanisms.

Hypertriglyceridemia-Associated Pancreatitis: New Concepts and Potential Mechanisms.

Journal: Clinical chemistry

Published: February 18, 2023

Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in the UK.

Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in the UK.

Journal: Human reproduction (Oxford, England)

Published: August 18, 2022

Elevated LDL Triglycerides and Atherosclerotic Risk.

Elevated LDL Triglycerides and Atherosclerotic Risk.

Journal: Journal of the American College of Cardiology

Published: August 04, 2022

Showing 1-12 of 65

Last Updated: 09/26/2026